Dave Kelly - SPDR SP Independent Trustee

XBI Etf  USD 98.85  1.22  1.25%   
Dave Kelly is Portfolio Manager at SPDR SP Biotech
David M. Kelly is President and CEO, NSCC Vice Chairman, DTCC Vice Chairman and CEO, Government Securities Clearing Corporationration . He also hold directoships in Chicago Stock Exchange Penson Worldwide Inc. Director Custodial Trust Co. streetTRACKS Index Shares Funds .
Tenure 24 years
IssuerSSgA
Inception Date2006-01-31
BenchmarkS&P Biotech Index
Entity TypeRegulated Investment Company
Asset Under Management7.33 Billion
Average Trading Valume10.57 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets

Similar Fund Executives

Found 2 records

One Year Return

John TuckerConsumer Discretionary Select
N/A
John TuckerHealth Care Select
N/A
In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States. SPDR SP Biotech [XBI] is traded in USA and was established 2006-01-31.

SPDR SP Biotech Money Managers

Gary French, Treasurer
John Clark, Assistant Treasurer
Dave Kelly, Independent Trustee
Helen Peters, Independent Trustee
Matthew Flaherty, Assistant Treasurer
Michael Riley, Vice President
Mary Zeven, Secretary
Chad Hallett, Assistant Treasurer of Street tracks series trust
Scott Zoltowski, Assistant Secretary
Peter Ambrosini, Chief Compliance Officer
James Ross, President Trustee
Frank Nesvet, Independent Trustee

SPDR Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is SPDR SP a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.